SOPHiA GENETICS SA SOPH 深 沪
已收盘 02-06 16:00:00 美东时间
4.80
+0.200
+4.35%
华盛通- 最 高4.93
- 今 开4.69
- 成交量 17.31万股
- 最 低 4.66
- 昨 收 4.60
- 总市值 3.26亿
- 52周最高 5.70
- 市盈率 静 --
- 换手率 0.26%
- 52周最低 2.58
- 委 比 17.60%
- 总股本 6784.71万
- 历史最高 19.80
- 量 比 0.46
- 振 幅 5.87%
- 历史最低 1.685
- 每 手 1
- 风险率 0.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SOPHiA GENETICS Secures Additional $25 Million Term Loan Commitments from Perceptive Credit Holdings
SOPHiA GENETICS Secures Additional $25 Million Term Loan Commitments from Perceptive Credit Holdings SOPHiA GENETICS SA has announced an amendment to its existing credit agreement with Perceptive Credit Holdings IV, LP, originally dated May 2, 2024. The Second Amendment, entered into on January 23,
01-29 05:10
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
Guggenheim Maintains Buy on Sophia Genetics, Raises Price Target to $7
Guggenheim analyst Subbu Nambi maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $6 to $7.
01-27 00:39
SOPHiA GENETICS Promotes Ross Muken To CEO, Effective July 2026, As Co‑Founder Jurgi Camblong Moves To Executive Chairman Role
Executive Transition PlanSOPHiA GENETICS today announced the promotion of Ross Muken to Chief Executive Officer, effective July 1, 2026. Mr. Muken, who currently serves as President and has been a key executive at the
01-12 20:07
SOPHiA GENETICS Expects FY26 Revenue Of $92M-$94M, up ~20%-22% YoY
Full Year 2026 GuidanceBased on information as of today, SOPHiA GENETICS is providing the following FY 2026 guidance:Full year revenue between $92 million and $94 million, representing approximately 20% to 22%
01-12 20:05
SOPHiA GENETICS Reports Preliminary Q4 Revenue Of At Least $21M, Representing Increase Of ~20% YoY; FY25 Preliminary Revenue Of ~77M, Up ~18% YoY
Fourth Quarter 2025 Preliminary Unaudited Financial ResultsRevenue of at least $21 million, representing an increase of approximately 20% year-over-yearPerformed over 105,000 analyses on SOPHiA DDM™ in the
01-12 20:04
SOPHiA Genetics inks two deals to advance AI for precision medicine
SOPHiA Genetics (SOPH) has signed partnerships with Complete Genomics and Element Biosciences to integrate the former's AI-powered analytics platforms with Complete's and Element's own sequencing plat...
2025-11-11 23:46
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $7
BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $6 to $7.
2025-11-10 17:52
A.D.A.M. Innovations与SOPHiA GENETICS达成战略合作
私营基因检测公司A.D.A.M. Innovations与引领数据驱动医学的AI技术公司SOPHiA GENETICS在欧洲肿瘤内科学会（ESMO）大会上宣布达...
2025-10-20 16:36
